Collegium Pharmaceutical | search
Click here to view Collegium Pharmaceutical news from 60+ newspapers.
Bookmark or Share- COLL Collegium Pharmaceutical, Inc. - Seeking AlphaA high-level overview of Collegium Pharmaceutical, Inc. (COLL) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
- Press Releases – Collegium Pharmaceutical Inc.STOUGHTON, Mass. , April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2024
- Collegium Pharmaceutical, Inc. (COLL) - Stock AnalysisCollegium Reports Third Quarter 2022 Financial Results. – Generated Record Net Revenue of $127.0 Million –. 1 year ago - GlobeNewsWire. Get a real-time Collegium Pharmaceutical, Inc. (COLL) stock price quote with breaking news, financials, statistics, charts and more.
- Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial ...STOUGHTON, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today reported its financial results for the quarter and full-year ended December 31, 2023, and provided a ...
- Collegium Pharmaceutical, Inc. (COLL) - Yahoo FinanceCollegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an...
More
